All filters
Slidesets
Update on Novel Combination Strategies - Marion Peters MD
Presented at:
International Workshop on HBV Cure 2020
Slidesets
Update on New Antiviral Targets Core Capsid Inhibitors (CpAMs) - Kosh Agarwal BMedSci (Hons) MD FRCP
Presented at:
International Workshop on HBV Cure 2020
Slidesets
Safety Monitoring for Investigational HBV Drugs and Discontinuation of HBV Therapy - Poonam Mishra MD, MPH, FAASLD
Presented at:
International Workshop on HBV Cure 2020
Slidesets
Toxicity in new and established HBV compounds - Jordan Feld, MD, MPH
Presented at:
International Workshop on HBV Cure 2020
Slidesets
How to interpret flares in HBV trials with novel agents - Pietro Lampertico, MD, PhD
Presented at:
International Workshop on HBV Cure 2020
Slidesets
Rationale for including immune tolerant and low viral load patients in new drug trials placeholder - Henry Lik Yeun Chan
Presented at:
International Workshop on HBV Cure 2020
Slidesets
Potential of new combinations to achieve functional cure for Chronic Hepatitis B - Fabien Zoulim, MD, PhD
Presented at:
International Workshop on HBV Cure 2020
Slidesets
Stopping Nucleos(t)ide Analogues: Clinical outcomes of HBs Loss, retreatment and flares- Pietro Lampertico, MD, PhD
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Immunological response after stopping Nucs- Andre Boonstra
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Virological biomarkers in patients stopping Nucs- Florian van Bommel, MD
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Review of the FDA/EMA HBV Endpoints Meeting- Fabien Zoulim, MD, PhD
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Are ALT Flares Associated with Improved Virological Clearance- Harry Janssen, MD, PhD
Presented at:
International Workshop on HBV Cure 2019
Slidesets
High Resolution of Exhausted T cells Ex Vivo in Chronic HBV Infection- Robert Thimme
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Restoration of B cell Antibody Production in Chronic HBV patients- Mala Maini, MD, PhD
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Are HBcrAg, HBV RNA and anti-HBc Viable Biomarkers- Florian van Bommel, MD
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Using FNAB to Investigate Intrahepatic Immunology- Adam Gehring, PhD
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Elimination of Residual HBV Replication and Prevention of cccDNA Generation with the Combination of NrtI and Core Inhibitor- Richard Colonno
Presented at:
International Workshop on HBV Cure 2019
Slidesets
sIRNA based therapy for Chronic Hepatitis B Treatment- Michael Biermer
Presented at:
International Workshop on HBV Cure 2019
Slidesets
NAP's latest update in HBV and HDV- Andrew Vaillant
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Study Design with New Combinations- Marion Peters, MD
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Hypothesized Synergies in new cobmination treatment beyond nucs- Jordan Feld, MD, MPH
Presented at:
International Workshop on HBV Cure 2019
Slidesets
TAF – The latest update, which questions remain to be answered?- Pietro Lampertico, MD, PhD
Presented at:
International Workshop on HBV Cure 2017